The PFI results indicated that an elevated ARPC2 expression predicted worse PFI in patients with ACC, HNSC, GBM, KIRC, KIRP, LGG, PAAD, PRAD, UCEC, and UVM (Supplementary Figure S2). This evidence concerns the gene ARPC2 and adrenal cortex carcinoma.